MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Smith & Nephew PLC ADR

Закрыт

33.65 -0.68

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

33.52

Макс.

33.89

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

29.768

87.826

Дивидендная доходность

2.29

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+5.46% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.29%

2.26%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

14B

Предыдущая цена открытия

34.33

Предыдущая цена закрытия

33.65

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 янв. 2026 г., 23:11 UTC

Отчет

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 янв. 2026 г., 22:55 UTC

Главные движущие силы рынка

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 янв. 2026 г., 21:39 UTC

Главные движущие силы рынка

Raytheon Down Following Trump Post Criticizing Company

7 янв. 2026 г., 20:13 UTC

Главные движущие силы рынка

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 янв. 2026 г., 20:03 UTC

Главные движущие силы рынка

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 янв. 2026 г., 23:46 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 янв. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 янв. 2026 г., 23:42 UTC

Приобретения, слияния, поглощения

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 янв. 2026 г., 23:34 UTC

Обсуждения рынка

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 янв. 2026 г., 23:29 UTC

Приобретения, слияния, поглощения

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 янв. 2026 г., 22:48 UTC

Обсуждения рынка

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 янв. 2026 г., 22:46 UTC

Отчет

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 янв. 2026 г., 22:45 UTC

Отчет

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 янв. 2026 г., 22:43 UTC

Приобретения, слияния, поглощения

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 янв. 2026 г., 22:42 UTC

Отчет

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 янв. 2026 г., 22:41 UTC

Отчет

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 янв. 2026 г., 22:41 UTC

Отчет

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 янв. 2026 г., 22:40 UTC

Главные движущие силы рынка

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 янв. 2026 г., 22:31 UTC

Обсуждения рынка

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 янв. 2026 г., 22:22 UTC

Обсуждения рынка

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 янв. 2026 г., 22:01 UTC

Обсуждения рынка

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 янв. 2026 г., 21:46 UTC

Обсуждения рынка

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 янв. 2026 г., 21:22 UTC

Приобретения, слияния, поглощения

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 янв. 2026 г., 21:18 UTC

Приобретения, слияния, поглощения

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 янв. 2026 г., 21:05 UTC

Приобретения, слияния, поглощения

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 янв. 2026 г., 20:29 UTC

Приобретения, слияния, поглощения

AbbVie Near Deal for Revolution Medicines -- Update

7 янв. 2026 г., 20:27 UTC

Обсуждения рынка

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 янв. 2026 г., 19:58 UTC

Обсуждения рынка

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 янв. 2026 г., 19:48 UTC

Главные движущие силы рынка

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

5.46% рост

Прогноз на 12 месяцев

Средняя 35.75 USD  5.46%

Максимум 37.5 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat